ArticleTherapeutic advances in gastroenterology2020

Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of

Mariko Hojo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.